Sickle Cell Disease - A Comprehensive Study and Usage of Technology for Diagnosis
Sagar Yeruva, M. Sharada Varalakshmi, B. Pavan Gowtham, Y. Hari Chandana, P. E. S. N. Krishna Prasad
International Blood Research & Reviews · pp. 6–14 · Published 19 Jun 2020
10.9734/ibrr/2020/v11i230125Abstract
Sickle cell is haematological disorder (haematology is a study of blood in health and diseases) which may lead to an organ damage, heart strokes and serious complications. It may also reduce human life span. Most of the sickle cells are observed in new born babies. At the start of sickle cells in human people though it’s a kind of feature in tribal people but it has spread over the world. Sickle cell Symptoms are observed in human beings as episodes of pains (crisis), Vision problems, swelling of hands and Feet. Sickle Cell Disease (SCD) can harm patient’s spleen (slightly pain at left Ribs). If one organ is affected in human body, then slowly it affects the entire body by spreading into Brain, Lungs, Heart, Liver, Kidneys, Joints, Eyes, Penis, Skin or Bone. This paper is aimed at presenting the complete details of the SCD with its properties, symptoms, signs, treatment for this disease. This is also a comprehensive study and characteristics of this disease with other similar diseases. The technological implications and usage in the field of SCD for better accuracy of identification of the disease is presented.
Cited by 0
No indexed citations yet.
Related research
- Comparison between Conventional Iron Chelating Medicine and Natural Iron Chelating Substance on Transfusion Dependent Thalassemia Patients - A Study from West Bengal, India — shares topic coverage
- Assessment of Serum Vitamin D, Ferritin and Bone Age in Children with Beta Thalassemia — shares topic coverage
- Early Diagnostics of Beta Thalassemia Minor — shares topic coverage
- Palliative Radiotherapy for Spinal Extramedullary Hematopoiesis in Thalassemia Major — shares topic coverage
- The Effect of Silymarin on Serum Concentration of Soluble Apoptosis Markers in β-Thalassemia Major Patients Receiving Desferrioxamine — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.